These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 9579567)

  • 1. Iatrogenic risks of endometrial carcinoma after treatment for breast cancer in a large French case-control study. Fédération Nationale des Centres de Lutte Contre le Cancer (FNCLCC).
    Mignotte H; Lasset C; Bonadona V; Lesur A; Luporsi E; Rodier JF; Cutuli B; Lasry S; Mauriac L; Granon C; Kerr C; Giard S; Hill C; de Lafontan B; de Gislain C; D'Anjou J; Fondrinier E; Lefeuvre C; Parache RM; Chauvin F
    Int J Cancer; 1998 May; 76(3):325-30. PubMed ID: 9579567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk and prognosis of endometrial cancer after tamoxifen for breast cancer. Comprehensive Cancer Centres' ALERT Group. Assessment of Liver and Endometrial cancer Risk following Tamoxifen.
    Bergman L; Beelen ML; Gallee MP; Hollema H; Benraadt J; van Leeuwen FE
    Lancet; 2000 Sep; 356(9233):881-7. PubMed ID: 11036892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endometrial cancer survival after breast cancer in relation to tamoxifen treatment: pooled results from three countries.
    Jones ME; van Leeuwen FE; Hoogendoorn WE; Mourits MJ; Hollema H; van Boven H; Press MF; Bernstein L; Swerdlow AJ
    Breast Cancer Res; 2012 Jun; 14(3):R91. PubMed ID: 22691381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endometrial cancer following breast cancer: Effect of tamoxifen and castration by radiotherapy.
    Sasco AJ; Chaplain G; Amoros E; Saez S
    Epidemiology; 1996 Jan; 7(1):9-13. PubMed ID: 8664408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A retrospective study of tamoxifen and endometrial cancer in breast cancer patients.
    Robinson DC; Bloss JD; Schiano MA
    Gynecol Oncol; 1995 Nov; 59(2):186-90. PubMed ID: 7590470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endometrial carcinoma following treatment for breast carcinoma in a Nigerian female. A case report and review of the literature.
    Abudu EK; Musa O; Adefuye PO; Abdul Kareem FB; Agboola AO; Banjo AA
    Niger Postgrad Med J; 2007 Dec; 14(4):355-7. PubMed ID: 18163149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of endometrial cancer in asymptomatic postmenopausal breast cancer patient treated with tamoxifen: a case report.
    Sinawat S; Chiyabutra T; Kleabkaew P
    J Med Assoc Thai; 2001 Jul; 84(7):1033-6. PubMed ID: 11759963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The incidence of subsequent endometrial carcinoma with tamoxifen use in patients with primary breast carcinoma.
    Katase K; Sugiyama Y; Hasumi K; Yoshimoto M; Kasumi F
    Cancer; 1998 May; 82(9):1698-703. PubMed ID: 9576291
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tamoxifen adjuvant treatment duration in early breast cancer: initial results of a randomized study comparing short-term treatment with long-term treatment. Fédération Nationale des Centres de Lutte Contre le Cancer Breast Group.
    Delozier T; Spielmann M; Macé-Lesec'h J; Janvier M; Hill C; Asselain B; Julien JP; Weber B; Mauriac L; Petit JC; Kerbrat P; Malhaire JP; Vennin P; Leduc B; Namer M
    J Clin Oncol; 2000 Oct; 18(20):3507-12. PubMed ID: 11032592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tamoxifen treatment for breast cancer and risk of endometrial cancer: a case-control study.
    Swerdlow AJ; Jones ME;
    J Natl Cancer Inst; 2005 Mar; 97(5):375-84. PubMed ID: 15741574
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tamoxifen therapy for breast cancer and endometrial cancer risk.
    Bernstein L; Deapen D; Cerhan JR; Schwartz SM; Liff J; McGann-Maloney E; Perlman JA; Ford L
    J Natl Cancer Inst; 1999 Oct; 91(19):1654-62. PubMed ID: 10511593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surveillance for uterine abnormalities in tamoxifen-treated breast carcinoma survivors: a community based study.
    Althuis MD; Sexton M; Langenberg P; Bush TL; Tkaczuk K; Magaziner J; Khoo L
    Cancer; 2000 Aug; 89(4):800-10. PubMed ID: 10951343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Population-based study of tamoxifen therapy and subsequent ovarian, endometrial, and breast cancers.
    Cook LS; Weiss NS; Schwartz SM; White E; McKnight B; Moore DE; Daling JR
    J Natl Cancer Inst; 1995 Sep; 87(18):1359-64. PubMed ID: 7658496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk of endometrial cancer after tamoxifen treatment of breast cancer.
    van Leeuwen FE; Benraadt J; Coebergh JW; Kiemeney LA; Gimbrère CH; Otter R; Schouten LJ; Damhuis RA; Bontenbal M; Diepenhorst FW
    Lancet; 1994 Feb; 343(8895):448-52. PubMed ID: 7905955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Uterine side effects of tamoxifen: a need for systematic pretreatment screening.
    Berlière M; Charles A; Galant C; Donnez J
    Obstet Gynecol; 1998 Jan; 91(1):40-4. PubMed ID: 9464718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The potential oncogenic effect of tamoxifen on the endometrium.
    Berlière M; Galant C; Donnez J
    Hum Reprod; 1999 May; 14(5):1381-3. PubMed ID: 10325299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Second cancers after adjuvant tamoxifen therapy for breast cancer in Japan.
    Matsuyama Y; Tominaga T; Nomura Y; Koyama H; Kimura M; Sano M; Miura S; Takashima S; Mitsuyama S; Ueo H; Ohashi Y
    Ann Oncol; 2000 Dec; 11(12):1537-43. PubMed ID: 11205460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. First results from the International Breast Cancer Intervention Study (IBIS-I): a randomised prevention trial.
    Cuzick J; Forbes J; Edwards R; Baum M; Cawthorn S; Coates A; Hamed A; Howell A; Powles T;
    Lancet; 2002 Sep; 360(9336):817-24. PubMed ID: 12243915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Endometrial cancer and tamoxifen. Discussion apropos of a series of cases].
    Sasco AJ; Ah-Song R; Gendre I; Zlatoff P; Bobin JY; Hallonet P; Leduc B
    Bull Cancer; 1997 Jan; 84(1):51-60. PubMed ID: 9180860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Utilization of gynecologic services in women with breast cancer receiving hormonal therapy.
    Wright JD; Desai VB; Chen L; Burke WM; Tergas AI; Hou JY; Accordino M; Ananth CV; Neugut AI; Hershman DL
    Am J Obstet Gynecol; 2017 Jul; 217(1):59.e1-59.e12. PubMed ID: 28341383
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.